Search

Your search keyword '"CANDIDA ORTHOPSILOSIS"' showing total 160 results

Search Constraints

Start Over You searched for: Descriptor "CANDIDA ORTHOPSILOSIS" Remove constraint Descriptor: "CANDIDA ORTHOPSILOSIS"
160 results on '"CANDIDA ORTHOPSILOSIS"'

Search Results

1. Evolution of loss of heterozygosity patterns in hybrid genomes of Candida yeast pathogens

2. Evolution of loss of heterozygosity patterns in hybrid genomes of Candida yeast pathogens.

3. Molecular Investigation of the Fatal Bloodstream Candida orthopsilosis Infection Case following Gastrectomy.

4. Threats from the Candida parapsilosis complex: the surge of multidrug resistance and a hotbed for new emerging pathogens.

5. Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases.

6. Hexane extract from Spiranthera odoratissima A. St.-hil. leaves: chemical composition and its bioactive potential against Candida pathogenic species, Leishmania amazonensis and Xylella fastidiosa.

7. Surface Treatment of Concrete by Calcium Carbonate Biodeposition Using Candida orthopsilosis.

8. Prevalence and Antifungal Susceptibility of Candida parapsilosis Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG

9. Beware of covert enemies: Candida orthopsilosis malignant otitis externa with base of the skull osteomyelitis, a case report and review of literature

10. Prevalence and Antifungal Susceptibility of Candida parapsilosis Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG.

11. The Transcriptional Aftermath in Two Independently Formed Hybrids of the Opportunistic Pathogen Candida orthopsilosis

12. Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates

13. Evaluation of Molecular Epidemiology, Clinical Characteristics, Antifungal Susceptibility Profiles, and Molecular Mechanisms of Antifungal Resistance of Iranian Candida parapsilosis Species Complex Blood Isolates.

14. Utility of two PCR‐RFLP‐based techniques for identification of Candida parapsilosis complex blood isolates.

16. Evolution of loss of heterozygosity patterns in hybrid genomes of Candida yeast pathogens

17. Evaluation of exoenzyme activities, biofilm formation, and co-hemolytic effect in clinical isolates of Candida parapsilosis species complex

18. Nowe gatunki w obrębie kompleksów Candida parapsilosis i Candida glabrata.

19. The first established microsatellite markers to distinguish Candida orthopsilosis isolates and detection of a nosocomial outbreak in China.

20. CORT0C04210 is required for Candida orthopsilosis adhesion to human buccal cells.

21. Molecular Genotyping of Candida parapsilosis Species Complex.

22. Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.

23. Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from Onychomycosis in Iran

24. Hexane extract from Spiranthera odoratissima A. St.-hil. leaves: chemical composition and its bioactive potential against Candida pathogenic species, Leishmania amazonensis and Xylella fastidiosa

25. A case of Candida orthopsilosis associated septic arthritis in a patient with Systemic Lupus Erythematosus (SLE)

26. Identificación molecular y sensibilidad a los antifúngicos de aislamientos de sangre del complejo Candida parapsilosis en Venezuela.

27. Utility of two PCR‐RFLP‐based techniques for identification of Candida parapsilosis complex blood isolates

28. Kinetic models application on glycerol production from glucose by the marine yeast Candida orthopsilosis

29. In Vitro Antifungal Activity of Ibrexafungerp (SCY-078) Against Contemporary Blood Isolates From Medically Relevant Species of Candida: A European Study

30. Candida parapsilosis complex water isolates from a haemodialysis unit: biofilm production and in vitro evaluation of the use of clinical antifungals

31. فراوانی گونه‌‌ها‌ی جدید کاندیدا (کاندیدا ارتوپسیلوزیس و کاندیدا متاپسیلوزیس) در بین گروه کاندیدا پاراپسیلوزیس‌‌ها‌ی جدا شده از بیماران با استفاده از ژن SADH و روش PCR-RFLP در ‌ایران

32. Postantifungal effect of caspofungin against the Candida albicans and Candida parapsilosis clades.

33. Metabolic profiles of planktonic and biofilm cells of Candida orthopsilosis.

34. Evaluation of exoenzyme activities, biofilm formation, and co-hemolytic effect in clinical isolates of Candida parapsilosis species complex.

35. Microbial Bioleaching of Ag, Au and Cu from Printed Circuit Boards of Mobile Phones

36. Characterization, antifungal susceptibility and virulence of Candida parapsilosis complex isolates in a tertiary hospital in Cantabria, Northern Spain.

37. The transcriptional aftermath in two independently formed hybrids of the opportunistic pathogen candida orthopsilosis

38. Utility of two PCR-RFLP-based techniques for identification of Candida parapsilosis complex blood isolates

39. Prevalence and Antifungal Susceptibility of Candida parapsilosis Species Complex in Eastern China: A 15-Year Retrospective Study by ECIFIG

40. Beware of covert enemies: Candida orthopsilosis malignant otitis externa with base of the skull osteomyelitis, a case report and review of literature

41. Candidaemia due to Candida parapsilosis species complex at a hospital in Brazil: Clinical characteristics and antifungal susceptibility profile.

42. Evaluation of the MALDI-TOF VITEK MS™ system for the identification of Candida parapsilosis, C. orthopsilosis and C. metapsilosis from bloodstream infections.

43. Comparison of Commercial Methods and the CLSI Broth Microdilution to Determine the Antifungal Susceptibility of Candida parapsilosis Complex Bloodstream Isolates from Three Health Institutions in Rio de Janeiro, Brazil.

44. Fungemia in a Spanish hospital: the role of Candida parapsilosis over a 15-year period.

45. Genome Comparison of Candida orthopsilosis Clinical Strains Reveals the Existence of Hybrids between Two Distinct Subspecies.

46. Candida orthopsilosis fungemias in a Spanish tertiary care hospital: Incidence, epidemiology and antifungal susceptibility.

47. Evaluation of in vivo pathogenicity of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis with different enzymatic profiles in a murine model of disseminated candidiasis.

48. Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis virulence in the non-conventional host Galleria mellonella.

49. Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP.

50. Genetska raznolikost in občutljivost za antimikotike kliničnih izolatov Candida parapsilosis

Catalog

Books, media, physical & digital resources